Tag: ADC
-
ADC Reduction & Conjugation Chemistry
Antibody drug conjugates (ADCs) are a type of targeted cancer therapy that combines the specificity of monoclonal antibodies with the potency of cytotoxic drugs. These innovative drugs have revolutionized the treatment of cancer by delivering potent drugs selectively to cancer cells, while sparing normal healthy cells from toxicity.
-
AI & Antibody Drug Conjugates (ADC)
Antibody drug conjugates (ADCs) are a promising class of therapeutics that combine the specificity of monoclonal antibodies with the potency of small molecule drugs. These conjugates are designed to target specific cancer cells and deliver a cytotoxic payload directly to the tumor, minimizing damage to healthy tissue. While ADCs have shown great potential, their development…
-
Cleavable Vs. Non-Cleavable Linkers in ADCs
Antibody drug conjugates (ADCs) are a class of targeted cancer therapies that combine the specificity of monoclonal antibodies (mAbs) with the cytotoxic potency of small molecule drugs. These complex molecules consist of three components: the mAb, the cytotoxic drug, and the linker that connects them. The linker plays a critical role in ADCs as it…
Biotech Informers 